Evaluation of a training and communication-network nephrology program for community pharmacists

Pharmacy World and Science

Volumn 30, Issue 6, 2008, Pages 924-933

  Lalonde, Lyne ^a,b   Normandeau, Michelle ^c   Lamarre, Diane ^a   Lord, Anne ^d   Berbiche, Djamal ^b   Corneille, Louise ^d   Prud'Homme, Louis ^d   Laliberté, Marie Claude ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Centre de Sante et de Services Sociaux de Laval   (Canada)

^c Public Health Department   (Canada)

^d Cite de la Sante de Laval   (Canada)

Author keywords

Canada; Chronic kidney disease; Cluster randomized controlled trial; Community pharmacy; Drug related problems; Pharmaceutical care; Pharmacist education

Indexed keywords

ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROLOGY; PATIENT EDUCATION; PATIENT INFORMATION; PHARMACIST; PHARMACY; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CHRONIC DISEASE; COMMUNICATION; COMMUNITY PHARMACY SERVICES; EDUCATION, PHARMACY, CONTINUING; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PILOT PROJECTS; PROFESSIONAL ROLE; QUALITY ASSURANCE, HEALTH CARE; REFERRAL AND CONSULTATION;

EID: 56549109643     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-008-9253-0     Document Type: Article

References (34)

1. AC Schoolwerth MM Engelgau TH Hostetter KH Rufo D Chianchiano WM McClellan 2006 Chronic kidney disease: a public health problem that needs a public health action plan Prev Chronic Dis 3 A57
2. S Thanamayooran C Rose DJ Hirsch 2005 Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets Nephrol Dial Transplant 20 2385 93 10.1093/ndt/gfi024
3. MD Wavamunno DC Harris 2005 The need for early nephrology referral Kidney Int Suppl 67 S128 32 10.1111/j.1523-1755.2005.09429.x
4. CA Johnson AS Levey J Coresh A Levin J Lau G Eknoyan 2004 Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors Am Fam Physician 70 869 76
5. MC Laliberté M Normandeau A Lord D Lamarre I Cantin D Berbiche 2007 Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency Am J Kidney Dis 49 245 56 10.1053/j.ajkd.2006.11.023
6. HJ Manley ML McClaran DK Overbay MA Wright GM Reid WL Bender 2003 Factors associated with medication-related problems in ambulatory hemodialysis patients Am J Kidney Dis 41 386 93 10.1053/ajkd.2003.50048
7. HJ Manley CA Cannella GR Bailie WL St Peter 2005 Medication-related problems in ambulatory hemodialysis patients: a pooled analysis Am J Kidney Dis 46 669 80 10.1053/j.ajkd.2005.07.001
8. RE Bennett RM DeHart SA Lauderdale 2006 Survey of care provided by ambulatory care pharmacists to patients with chronic kidney disease Am J Health Syst Pharm 63 2123 7 10.2146/ajhp050522
9. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis. 2003;41:I-IV, S1-91.
10. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1-201.
11. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
12. IV. NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis. 2001;37:S182-238. doi: 10.1016/S0272-6386(01)70008-X.
13. MD Philipneri LA Rocca Rey MA Schnitzler KC Abbott DC Brennan SK Takemoto 2008 Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review Clin Exp Nephrol 12 41 52 10.1007/s10157-007-0016-3
14. AJ Zillich JJ Saseen RM Dehart P Dumo DW Grabe C Gilmartin 2005 Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy Pharmacotherapy 25 123 43 10.1592/phco.25.1.123.55628
15. EJ Jones NJ Mackinnon RT Tsuyuki 2005 Pharmaceutical care in community pharmacies: practice and research in Canada Ann Pharmacother 39 1527 33 10.1345/aph.1E456
16. E Kröger J Moisan JP Grégoire 2000 Billing for cognitive services: understanding Quebec pharmacists' behavior Ann Pharmacother 34 309 16 10.1345/aph.19133
17. Rapports d'études et statistiques, Régie de l'assurance maladie du Québec. Available at: http://www.ramq.gouv.qc.ca/fr/ statistiques/index.shtml. Accessed 14 July 2008.
18. GR Matzke WL St Peter TJ Comstock EF Foote 2000 Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment Ann Pharmacother 34 593 9 10.1345/aph.19245
19. R Rouleau MF Beauchesne C Laurier 2007 Impact of a continuing education program on community pharmacists' interventions and asthma medication use: a pilot study Ann Pharmacother 41 574 80 10.1345/aph.1H606
20. L Dolovich M Sabharwal K Agro G Foster A Lee L McCarthy 2007 The effect of pharmacist education on asthma treatment plans for simulated patients Pharm World Sci 29 228 39 10.1007/s11096-006-9080-0
21. Murray DM. Planning the analysis. In: Murray DM, editor. Design and analysis of group-randomized trials (ISBN 0-19-512036-1). UK: Oxford University Press; 1998. p. 77-130.
22. KD Riley LD Wazny 2006 Assessment of a fax document for transfer of medication information to family physicians and community pharmacists caring for hemodialysis outpatients CANNT J 16 24 8
23. N Paquette-Lamontagne WM McLean L Besse J Cusson 2001 Evaluation of a new integrated discharge prescription form Ann Pharmacother 35 953 8 10.1345/aph.10244
24. L Pickrell C Duggan S Dhillon 2001 From hospital admission to discharge: an exploratory study to evaluate seamless care Pharm J 267 650 3
25. C Duggan R Feldman J Hough I Bates 1998 Reducing adverse prescribing discrepancies following hospital discharge Int J Pharm Pract 6 77 82
26. JL Schnipper JL Kirwin MC Cotugno SA Wahlstrom BA Brown E Tarvin 2006 Role of pharmacist counseling in preventing adverse drug events after hospitalization Arch Intern Med 166 565 71 10.1001/archinte.166.5.565
27. W McLean 1997 Experience with a new prescription and discharge note form to improve seamless care Can J Hosp Pharm 50 257 letter
28. MJ Liddell SP Goldman 1998 Attitudes to and use of a modified prescription form by general practitioners and pharmacists Med J Aust 168 322 5
29. DW Bates LL Leape DJ Cullen N Laird LA Petersen JM Teich 1998 Effect of computerized physician order entry and a team intervention on prevention of serious medication errors JAMA 280 1311 6 10.1001/jama.280.15.1311
30. N Klar A Donner 2001 Current and future challenges in the design and analysis of cluster randomization trials Stat Med 20 3729 40 10.1002/sim.1115
31. Moore H, Summerbell C, Vail A, Greenwood DC, Adamson AJ. The design features and practicalities of conducting a pragmatic cluster randomized trial of obesity management in primary care. Stat Med. 2001;20:331-40. doi:10.1002/1097-0258(20010215)20:3<331::AID-SIM795>3.0.CO;2-K.
32. S Puffer D Torgerson J Watson 2003 Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals BMJ 327 785 9 10.1136/bmj.327.7418.785
33. S Hahn S Puffer DJ Torgerson J Watson 2005 Methodological bias in cluster randomised trials BMC Med Res Methodol 5 10 10.1186/1471-2288-5-10
34. DJ Torgerson 2001 Contamination in trials: is cluster randomisation the answer? BMJ 322 355 7 10.1136/bmj.322.7282.355